Brief: Ac Immune’S Pi-2620 Tau-Pet Diagnostic In Phase 3 Receives Fast Track Designation
28/08/2024 14:03
Aug 28 (Reuters) - AC Immune SA ACIU.O :
* AC IMMUNE’S PI-2620 TAU-PET DIAGNOSTIC IN PHASE 3 RECEIVES
FAST
TRACK DESIGNATION IN THREE NEURODEGENERATIVE CONDITIONS
Source text for Eikon: ID:nGNX1Lw7TL
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture